Baker Boyer National Bank’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-24,607
Closed -$308K 84
2023
Q2
$308K Hold
24,607
0.11% 72
2023
Q1
$287K Hold
24,607
0.11% 70
2022
Q4
$262K Hold
24,607
0.11% 70
2022
Q3
$239K Buy
24,607
+10,226
+71% +$135K 0.11% 72
2022
Q2
$208K Sell
14,381
-30,230
-68% -$515K 0.11% 78
2022
Q1
$1.17M Hold
44,611
0.56% 25
2021
Q4
$1.77M Buy
+44,611
New +$2.03M 0.81% 22
2021
Q2
$208K Buy
+14,381
New +$766K 0.11% 78

Other funds holding HCAT

Baker Boyer National Bank's HCAT Position: Q3 2023 in Review

Baker Boyer National Bank sold out of Health Catalyst (HCAT) in Q3 2023, closing a stake of 24,607 shares — an estimated $308K sold.

Baker Boyer National Bank first reported a position in HCAT in Q2 2021 and held it in 8 quarters. The position peaked at $1.77M in Q4 2021. 159 funds tracked by Wall St. Rank hold HCAT as of Q3 2023.

  • Baker Boyer National Bank reported no remaining Health Catalyst position as of Q3 2023 after selling out during the quarter.
  • Baker Boyer National Bank sold 24,607 Health Catalyst shares in Q3 2023, an estimated $308K.
  • Baker Boyer National Bank first reported a position in Health Catalyst in Q2 2021 and held it in 8 quarters.
  • Baker Boyer National Bank's Health Catalyst position peaked at $1.77M in Q4 2021.
  • 159 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2023.

Based on Baker Boyer National Bank's 13F filing for Q3 2023, filed 12 Oct 2023.